HomeMBIO • NASDAQ
add
Mustang Bio Inc
Nakaraang pagsara
$0.20
Sakop ng taon
$0.13 - $1.66
Market cap
9.80M USD
Average na Volume
3.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.46M | -87.50% |
Net na kita | -1.41M | 85.98% |
Net profit margin | — | — |
Kita sa bawat share | -0.04 | 97.14% |
EBITDA | -1.41M | 87.64% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.52M | -63.14% |
Kabuuang asset | 7.19M | -65.03% |
Kabuuang sagutin | 15.85M | -4.28% |
Kabuuang equity | -8.66M | — |
Natitirang share | 47.72M | — |
Presyo para makapag-book | -0.87 | — |
Return on assets | -46.37% | — |
Return on capital | 48.83% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.41M | 85.98% |
Cash mula sa mga operasyon | -1.76M | 85.39% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 1.01M | 305.60% |
Net change in cash | -743.00K | 87.24% |
Malayang cash flow | -1.20M | 51.19% |
Tungkol
Mustang Bio is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Itinatag
2015
Headquarters
Website
Mga Empleyado
80
